Vertex Pharmaceuticals (VRTX) News Today $495.83 +11.61 (+2.40%) As of 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period Brokerages Set Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Price Target at $509.17April 14 at 2:51 AM | americanbankingnews.comZacks Research Has Optimistic Outlook of VRTX Q1 EarningsVertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) - Investment analysts at Zacks Research upped their Q1 2027 earnings per share (EPS) estimates for shares of Vertex Pharmaceuticals in a report released on Wednesday, April 9th. Zacks Research analyst R. Department now forecasts thatApril 13 at 8:17 AM | marketbeat.comMonetary Management Group Inc. Has $244,000 Holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Monetary Management Group Inc. decreased its stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 48.3% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 605 shares of the pharmaceutical company'sApril 13 at 8:01 AM | marketbeat.comKennedy Capital Management LLC Has $9.51 Million Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Kennedy Capital Management LLC raised its position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 74.5% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 23,61April 13 at 6:45 AM | marketbeat.comDRW Securities LLC Makes New $479,000 Investment in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)DRW Securities LLC acquired a new stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor acquired 1,189 shares of the pharmaceutical company'April 13 at 6:08 AM | marketbeat.comAdvisory Services Network LLC Lowers Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Advisory Services Network LLC decreased its stake in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 10.2% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 6,796 shares of the phApril 13 at 5:55 AM | marketbeat.comFIL Ltd Has $37.56 Million Stock Holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)FIL Ltd boosted its holdings in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 1,226.6% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 93,273 shares of the pharmaceutical company'April 13 at 5:35 AM | marketbeat.comZacks Research Has Positive Estimate for VRTX Q1 EarningsApril 13 at 2:01 AM | americanbankingnews.comVertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Given Average Recommendation of "Moderate Buy" by BrokeragesShares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Get Free Report) have been assigned an average rating of "Moderate Buy" from the twenty-six research firms that are presently covering the stock, MarketBeat reports. Ten equities research analysts have rated the stock with a hold rating,April 13 at 1:21 AM | marketbeat.comVertex Pharmaceuticals (VRTX) Celebrated for Groundbreaking CF ResearchApril 12 at 12:03 PM | gurufocus.comAndrew Hill Investment Advisors Inc. Sells 2,335 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Andrew Hill Investment Advisors Inc. cut its holdings in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 26.3% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 6,554 sharesApril 12 at 9:24 AM | marketbeat.comVertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Shares Acquired by Treasurer of the State of North CarolinaTreasurer of the State of North Carolina increased its position in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 0.4% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 116,793 shares of the pharmaceutical company'sApril 12 at 8:47 AM | marketbeat.comF M Investments LLC Has $12.45 Million Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)F M Investments LLC cut its position in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 27.2% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 30,915 shares of the pharmaceutical company's stocApril 12 at 7:15 AM | marketbeat.comBank of Nova Scotia Reduces Stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Bank of Nova Scotia cut its position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 36.9% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 47,097 shares of the pharmaceutical company'sApril 12 at 6:21 AM | marketbeat.comNasdaq Market Whiplash: 3 Stocks to Buy Hand Over Fist and Hold for DecadesApril 12 at 4:48 AM | fool.comAPG Asset Management US Inc. Sells 666 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)APG Asset Management US Inc. lowered its stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 11.1% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 5,334 shares of the pharmaceutical company's stApril 11 at 7:28 AM | marketbeat.comVertex Pharmaceuticals Inc (VRTX) Celebrates Prestigious Award for Cystic Fibrosis Research | ...April 11 at 7:08 AM | gurufocus.comMartingale Asset Management L P Lowers Stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Martingale Asset Management L P lessened its holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 4.0% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 51,207 sharesApril 11 at 6:55 AM | marketbeat.comAzimuth Capital Investment Management LLC Has $8.92 Million Holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Azimuth Capital Investment Management LLC lifted its stake in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 3.3% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 22,141 shares of the pApril 11 at 6:54 AM | marketbeat.comVertex Researcher, Paul Negulescu Ph.D., Receives the 2025 Canada Gairdner International Award for Pioneering Research and Discovery of Medicines for Cystic FibrosisApril 11 at 5:30 AM | businesswire.comArrowstreet Capital Limited Partnership Takes $3.73 Million Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Arrowstreet Capital Limited Partnership purchased a new stake in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor puApril 11 at 4:03 AM | marketbeat.comVertex Pharmaceuticals (VRTX) Surged on Increased Demand for its Cystic Fibrosis (CF) FranchiseApril 10, 2025 | insidermonkey.comAPG Asset Management N.V. Raises Stock Holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)APG Asset Management N.V. increased its stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 189.7% in the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 359,285 shares of the pharmaceutical company's stock afteApril 10, 2025 | marketbeat.comRenaissance Technologies LLC Reduces Holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Renaissance Technologies LLC lowered its holdings in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 14.4% in the fourth quarter, according to its most recent disclosure with the SEC. The firm owned 1,397,209 shares of the pharmaceutical company's stock after selling 23April 10, 2025 | marketbeat.comShelton Capital Management Buys 647 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Shelton Capital Management raised its position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 1.2% during the fourth quarter, according to its most recent 13F filing with the SEC. The fund owned 54,631 shares of the pharmaceutical company's stock after buying an additional 64April 10, 2025 | marketbeat.comVertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Stock Position Lessened by Twin Capital Management Inc.Twin Capital Management Inc. lowered its stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 49.1% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 2,933 shares of the pharmaceutical company's stocApril 10, 2025 | marketbeat.comInvesco Ltd. Trims Stock Holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Invesco Ltd. lowered its holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 2.3% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,898,457 shares of the pharmaceutical company'sApril 10, 2025 | marketbeat.comBank of Montreal Can Has $234.04 Million Stock Holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Bank of Montreal Can increased its position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 4.3% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 581,181 shares of the pharmaceuticaApril 10, 2025 | marketbeat.comPolymer Capital Management US LLC Takes Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Polymer Capital Management US LLC purchased a new position in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm purchased 816 shares of the pharmaceutical compApril 10, 2025 | marketbeat.comWe're About to Find Out the Answer to Warren Buffett's Pointed Question About Trump's Tariffs. Here Are 3 Stocks to Buy Depending on What That Answer Is.April 10, 2025 | fool.comAn Intrinsic Calculation For Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Suggests It's 41% UndervaluedApril 9, 2025 | finance.yahoo.comMorgan Stanley Remains a Hold on Vertex Pharmaceuticals (VRTX)April 9, 2025 | markets.businessinsider.comVertex Pharmaceuticals price target raised to $462 from $459 at Morgan StanleyApril 9, 2025 | markets.businessinsider.com5 Top Growth Stocks to Buy in the Stock Market Sell-OffApril 9, 2025 | fool.com5 Top Growth Stocks to Buy in the Stock Market Sell-OffApril 9, 2025 | fool.comVertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Shares Sold by Legal & General Group PlcLegal & General Group Plc cut its stake in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 18.2% in the fourth quarter, according to its most recent disclosure with the SEC. The firm owned 1,884,153 shares of the pharmaceutical company's stock after selling 419,644 sharApril 9, 2025 | marketbeat.comVertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Position Boosted by Employees Retirement System of TexasEmployees Retirement System of Texas raised its holdings in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 3.1% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 121,600April 9, 2025 | marketbeat.comCerity Partners LLC Grows Stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Cerity Partners LLC increased its stake in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 3.9% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 238,029 shares of the pharmaceutical compApril 9, 2025 | marketbeat.comFederated Hermes Inc. Sells 2,864 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Federated Hermes Inc. lessened its holdings in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 1.5% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 189,075 shares of the pharmaceutical companApril 9, 2025 | marketbeat.comEnvestnet Asset Management Inc. Increases Stock Holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Envestnet Asset Management Inc. increased its holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 4.9% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 422,698 shares of the pharmApril 9, 2025 | marketbeat.comVertex Pharmaceuticals announces EC approval of expanded KAFTRIO labelApril 8, 2025 | markets.businessinsider.comIs Vertex Pharmaceuticals Stock a Buy?April 8, 2025 | fool.comFmr LLC Reduces Stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Fmr LLC decreased its position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 12.4% during the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 9,219,046 shares of the pharmaceutical company's stock after selling 1,305,967 shares during the peApril 8, 2025 | marketbeat.comEdgewood Management LLC Acquires 1,410,238 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Edgewood Management LLC increased its stake in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 91.2% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 2,956,608 shares of the pharmaceutical company's stock after purcApril 8, 2025 | marketbeat.comIlmarinen Mutual Pension Insurance Co Increases Stock Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Ilmarinen Mutual Pension Insurance Co boosted its position in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 45.1% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor ownApril 8, 2025 | marketbeat.comRussell Investments Group Ltd. Buys 9,377 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Russell Investments Group Ltd. boosted its stake in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 4.1% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investorApril 8, 2025 | marketbeat.comAviva PLC Has $62.62 Million Stock Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Aviva PLC increased its stake in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 24.6% during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 155,490 shares of the pharmaceutical company's stock after acquiring anApril 8, 2025 | marketbeat.com1,283 Shares in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Bought by Landscape Capital Management L.L.C.Landscape Capital Management L.L.C. bought a new stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 1,283 shareApril 8, 2025 | marketbeat.comThoroughbred Financial Services LLC Acquires New Holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Thoroughbred Financial Services LLC bought a new position in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor boughtApril 8, 2025 | marketbeat.comVertex Pharmaceuticals Inc (VRTX) Announces First Quarter 2025 Financial Results ReleaseApril 7, 2025 | gurufocus.com Remove Ads Get Vertex Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for VRTX and its competitors with MarketBeat's FREE daily newsletter. Email Address VRTX Media Mentions By Week VRTX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. VRTX News Sentiment▼1.290.86▲Average Medical News Sentiment VRTX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. VRTX Articles This Week▼5625▲VRTX Articles Average Week Remove Ads Get Vertex Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for VRTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Amgen News Gilead Sciences News Regeneron Pharmaceuticals News Alnylam Pharmaceuticals News Biogen News United Therapeutics News Incyte News BioMarin Pharmaceutical News Exelixis News Neurocrine Biosciences News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:VRTX) was last updated on 4/14/2025 by MarketBeat.com Staff From Our PartnersWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredClaim Your FREE Protection GuideIn the final days of his first term, Trump quietly left open an "off the books" wealth-protection loophole hid...American Alternative | SponsoredAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredTariffs. Volatility. Fear. Here’s the Plan.Wall Street's panicking over tariffs. Volatility's back with a vengeance. If you've been glued to the he...Investors Alley | SponsoredCatastrophicThe losses are catastrophic... $760 billion wiped off the Magnificent 7, in a single day.InvestorPlace | SponsoredTrump’s betrayal exposed Whether you agree with the plan or not doesn’t matter. It’s happening. The only question is – are you re...Porter & Company | SponsoredTrump 2028 could be a “bonanza” for investorsAs you may have heard, Donald Trump is planning to run for a THIRD term in 2028. Recently he told NBC news ...Paradigm Press | SponsoredIf Gold Is ‘Stalling,’ Why Are Banks Hoarding Billions In Secret?Prosperity was something every American family could build, protect, and pass down. Because that's what legacy...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vertex Pharmaceuticals Incorporated Please log in to your account or sign up in order to add this asset to your watchlist. Share Vertex Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy VRTX Stock Free VRTX Stock Alerts